146 related articles for article (PubMed ID: 26241178)
1. Characterization of V0162, a new long-acting antagonist at human M3 muscarinic acetylcholine receptors.
Heusler P; Cussac D; Naline E; Tardif S; Clerc T; Devillier P
Pharmacol Res; 2015 Oct; 100():117-26. PubMed ID: 26241178
[TBL] [Abstract][Full Text] [Related]
2. Bronchodilator activity of (3R)-3-[[[(3-fluorophenyl)[(3,4,5-trifluorophenyl)methyl]amino] carbonyl]oxy]-1-[2-oxo-2-(2-thienyl)ethyl]-1-azoniabicyclo[2.2.2]octane bromide (CHF5407), a potent, long-acting, and selective muscarinic M3 receptor antagonist.
Villetti G; Pastore F; Bergamaschi M; Bassani F; Bolzoni PT; Battipaglia L; Amari G; Rizzi A; Delcanale M; Volta R; Cenacchi V; Cacciani F; Zaniboni M; Berti F; Rossoni G; Harrison S; Petrillo P; Santoro E; Scudellaro R; Mannini F; Geppetti PA; Razzetti R; Patacchini R; Civelli M
J Pharmacol Exp Ther; 2010 Dec; 335(3):622-35. PubMed ID: 20805306
[TBL] [Abstract][Full Text] [Related]
3. The in vitro and in vivo profile of aclidinium bromide in comparison with glycopyrronium bromide.
Gavaldà A; Ramos I; Carcasona C; Calama E; Otal R; Montero JL; Sentellas S; Aparici M; Vilella D; Alberti J; Beleta J; Miralpeix M
Pulm Pharmacol Ther; 2014 Aug; 28(2):114-21. PubMed ID: 24928173
[TBL] [Abstract][Full Text] [Related]
4. Molecular hybridization yields triazole bronchodilators for the treatment of COPD.
Jones LH; Burrows J; Feeder N; Glossop P; James K; Jones RM; Kenyon AS; Patel S; Roberts DF; Selby MD; Strang RS; Stuart EF; Trevethick MA; Watson J; Wright KN; Clarke N
Bioorg Med Chem Lett; 2015 Nov; 25(22):5121-6. PubMed ID: 26471092
[TBL] [Abstract][Full Text] [Related]
5. Characterization of aclidinium bromide, a novel inhaled muscarinic antagonist, with long duration of action and a favorable pharmacological profile.
Gavaldà A; Miralpeix M; Ramos I; Otal R; Carreño C; Viñals M; Doménech T; Carcasona C; Reyes B; Vilella D; Gras J; Cortijo J; Morcillo E; Llenas J; Ryder H; Beleta J
J Pharmacol Exp Ther; 2009 Nov; 331(2):740-51. PubMed ID: 19710368
[TBL] [Abstract][Full Text] [Related]
6. [Regulation of bronchial tone in chronic obstructive pulmonary disease (COPD): role of muscarinic receptors].
Abad Santos F; Novalbos J; Gallego Sandín S; Gálvez Múgica MA
An Med Interna; 2003 Apr; 20(4):201-5. PubMed ID: 12768836
[TBL] [Abstract][Full Text] [Related]
7. Bronchodilatory effects of S-isopetasin, an antimuscarinic sesquiterpene of Petasites formosanus, on obstructive airway hyperresponsiveness.
Lin LH; Huang TJ; Wang SH; Lin YL; Wu SN; Ko WC
Eur J Pharmacol; 2008 Apr; 584(2-3):398-404. PubMed ID: 18348887
[TBL] [Abstract][Full Text] [Related]
8. V0162 a new long-acting bronchodilator for treatment of chronic obstructive lung diseases: preclinical and clinical results.
Devillier P; Garrigue E; D'Auzers G; Monjotin N; Similowski T; Clerc T
Respir Res; 2015 Jun; 16(1):68. PubMed ID: 26050967
[TBL] [Abstract][Full Text] [Related]
9. Tiotropium bromide (Ba 679 BR), a novel long-acting muscarinic antagonist for the treatment of obstructive airways disease.
Barnes PJ; Belvisi MG; Mak JC; Haddad EB; O'Connor B
Life Sci; 1995; 56(11-12):853-9. PubMed ID: 10188785
[TBL] [Abstract][Full Text] [Related]
10. Preclinical evaluation of long-acting muscarinic antagonists: comparison of tiotropium and investigational drugs.
Casarosa P; Bouyssou T; Germeyer S; Schnapp A; Gantner F; Pieper M
J Pharmacol Exp Ther; 2009 Aug; 330(2):660-8. PubMed ID: 19478135
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of GSK573719 (umeclidinium): a novel, long-acting, inhaled antagonist of the muscarinic cholinergic receptors for treatment of pulmonary diseases.
Salmon M; Luttmann MA; Foley JJ; Buckley PT; Schmidt DB; Burman M; Webb EF; DeHaas CJ; Kotzer CJ; Barrett VJ; Slack RJ; Sarau HM; Palovich MR; Lainé DI; Hay DW; Rumsey WL
J Pharmacol Exp Ther; 2013 May; 345(2):260-70. PubMed ID: 23435542
[TBL] [Abstract][Full Text] [Related]
12. In vivo pharmacological characterization of TD-4208, a novel lung-selective inhaled muscarinic antagonist with sustained bronchoprotective effect in experimental animal models.
Pulido-Rios MT; McNamara A; Obedencio GP; Ji Y; Jaw-Tsai S; Martin WJ; Hegde SS
J Pharmacol Exp Ther; 2013 Aug; 346(2):241-50. PubMed ID: 23685545
[TBL] [Abstract][Full Text] [Related]
13. The Influence of receptor kinetics on the onset and duration of action and the therapeutic index of NVA237 and tiotropium.
Sykes DA; Dowling MR; Leighton-Davies J; Kent TC; Fawcett L; Renard E; Trifilieff A; Charlton SJ
J Pharmacol Exp Ther; 2012 Nov; 343(2):520-8. PubMed ID: 22854200
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the in vitro pharmacological profiles of long-acting muscarinic antagonists in human bronchus.
Naline E; Grassin Delyle S; Salvator H; Brollo M; Faisy C; Victoni T; Abrial C; Devillier P
Pulm Pharmacol Ther; 2018 Apr; 49():46-53. PubMed ID: 29337266
[TBL] [Abstract][Full Text] [Related]
15. [Tiotropium bromide for treating chronic obstructive pulmonary disease].
Uteshev DB; Buniatian ND; Kovaleva VL
Eksp Klin Farmakol; 2010 Nov; 73(11):15-8. PubMed ID: 21254592
[TBL] [Abstract][Full Text] [Related]
16. [Tiotropium as a controller of bronchoconstriction].
Lubiński W
Pol Merkur Lekarski; 2004 May; 16 Suppl 1():75-6, 78. PubMed ID: 15524023
[TBL] [Abstract][Full Text] [Related]
17. Second M
Kistemaker LEM; Elzinga CRS; Tautermann CS; Pieper MP; Seeliger D; Alikhil S; Schmidt M; Meurs H; Gosens R
Br J Pharmacol; 2019 Aug; 176(16):2864-2876. PubMed ID: 31077341
[TBL] [Abstract][Full Text] [Related]
18. Comparative characterization of lung muscarinic receptor binding after intratracheal administration of tiotropium, ipratropium, and glycopyrrolate.
Ogoda M; Niiya R; Koshika T; Yamada S
J Pharmacol Sci; 2011; 115(3):374-82. PubMed ID: 21358117
[TBL] [Abstract][Full Text] [Related]
19. The constitutive activity of the human muscarinic M3 receptor unmasks differences in the pharmacology of anticholinergics.
Casarosa P; Kiechle T; Sieger P; Pieper M; Gantner F
J Pharmacol Exp Ther; 2010 Apr; 333(1):201-9. PubMed ID: 20035022
[TBL] [Abstract][Full Text] [Related]
20. Characterization of bencycloquidium bromide, a novel muscarinic M(3) receptor antagonist in guinea pig airways.
Jiang JX; Cao R; Deng WD; Jin F; Dong XW; Zhu Y; Chen XP; Xie YC; Bao MJ; Li FF; Xie QM
Eur J Pharmacol; 2011 Mar; 655(1-3):74-82. PubMed ID: 21272572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
